CR Intrinsic Investors’s NxStage Medical Inc. NXTM Stock Holding History

CR Intrinsic Investors’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-800,000	Closed	-$10.2M	–	207
2014 Q1	$10.2M	Buy	+800,000	New	+$10.4M	0.38%	94
2013 Q3	–	Sell	-119,947	Closed	-$1.71M	–	433
2013 Q2	$1.71M	Buy	+119,947	New	+$1.51M	0.06%	283

Other funds holding NXTM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Broadview Advisors Milwaukee, Wisconsin $324M AUM 0.76% 1-Year Est. Return

CR Intrinsic Investors's NXTM Position: Q2 2014 in Review

CR Intrinsic Investors sold out of NxStage Medical Inc. (NXTM) in Q2 2014, closing a stake of 800,000 shares — an estimated $10.2M sold.

CR Intrinsic Investors first reported a position in NXTM in Q2 2013 and held it in 2 quarters. The position peaked at $10.2M in Q1 2014. 115 funds tracked by Wall St. Rank hold NXTM as of Q2 2014.

CR Intrinsic Investors reported no remaining NxStage Medical Inc. position as of Q2 2014 after selling out during the quarter.
CR Intrinsic Investors sold 800,000 NxStage Medical Inc. shares in Q2 2014, an estimated $10.2M.
CR Intrinsic Investors first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 2 quarters.
CR Intrinsic Investors's NxStage Medical Inc. position peaked at $10.2M in Q1 2014.
115 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q2 2014.

Based on CR Intrinsic Investors's 13F filing for Q2 2014.